Milestone Scientific Inc (MLSS)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
$0.33+8.26%
Close 2026-11-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · MLSS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -60.4% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 17.5% |
Growth built into the price is above our model estimate.
The price assumes 77.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 11 industry peers
MLSS — private placement
Dated 2026-07-29
Other Events On July 24, 2026, Milestone Scientific Inc. (the “Company”) received notices of conversion (the “Conversion Notices”) from Benedetta Casamento, Dr. Didier Demesmin and Neal Goldman, each of whom is a director of the Company (collectively, the “Holders”), with respect to the Company’s amended and restated promissory notes held by the Holders (the “Convertible Bridge Notes”). As previously disclosed, the Convertible Bridge Notes were originally issued in an aggregate principal amou…
Why it matters: Cash from operations fell to negative $585,000 in Q2 after a positive Q1. Another negative quarter would show that cash flow remains uneven.
Watch forQ3 cash from operations is above zero.
Also watch forQ3 cash from operations is below zero.
Why it matters: Management has pursued expansion through Innovest agreements, but the inputs show no near-term financial payoff yet. A named deal step would show progress.
Supportive ifA company filing names a new Innovest deal, a completed deal, or revenue from a deal.
Worry ifThe company says an Innovest deal ended, was delayed, or brings in no material revenue.
Why it matters: The company still loses money, despite recent sales growth. A smaller operating loss would show it is closer to covering costs.
Watch forQ3 operating loss is smaller than $1.06 million, the Q2 loss.
Also watch forQ3 operating loss is larger than $1.06 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$282 on $10,000 · ±2.8% | How much price usually moves either way. |
| Bad day | $774 loss on $10,000 · 7.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,575 loss on $10,000 · 45.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.